Metrion's leadership team has 125+ years' combined experience in drug discovery, 100 years of which is working in the ion channel field. This wealth of expertise is cited in ~150 publications and underpins our commitment to delivering world-class ion channel screening and drug discovery services. Our senior scientists and executives bring decades of experience across pharmaceutical R&D, biotech innovation, and CRO operations. From shaping scientific strategy to ensuring operational excellence, each leader plays a vital role in Metrion's success and delivering quality results for our customers.
Lee specialises in steering preclinical CROs to implement robust and effective plans for long-term commercial growth.
Rob is a skilled pharmacologist with over 10 years’ experience in ion channel drug discovery.
Eddy has over 25 years of experience in ion channel drug discovery and is widely published.
Gary has over 25 years of experience in ion channel drug discovery, including more than 20 years in contract research.
Tony has over 25 years of experience in the ion channel field, spanning both academic research and industry and is widely published.
Chris has over 25 years of experience in the biopharmaceutical industry, with a strong background in preclinical CRO leadership, sales and marketing.
Steve has over 25 years of experience in drug discovery and in vitro safety pharmacology within the pharmaceutical industry. He is a recognised thought leader in his field, with deep expertise in secondary pharmacology.
John has been working in the ion channel field for over 20 years.
Sophie has a PhD in Chemistry. She joined Metrion in 2018 and is responsible for sales and business development in the UK and Europe.
Sue is a hands-on marketing leader who manages Metrion's global marketing operations.
